Totipro® PE0401
Our Glac Biotech postbiotics are produced through a patented "Pronex™" technology. Postbiotics are produced using a high density fermentation technology to maximise the metabolites from Glac Biotech's own probiotic strains. Glac's PE0401, winner of the best product for gut modulation at the Nutra Ingredients awards in Asia, comprises of metabolites from four Glac Biotech strains:- Lactobacillus plantarum LPL28 Lactobacillus salivarius AP-32 Bifidobacterium longum subsp. infantis BLI-02 Lactobacillus acidophilus TYCA06 Clinical studies include:- - Digestive health (bowel movement, improved abdominal comfort, diarrhea and constipation. - Improved Gut microbiota (improved levels and balance of gut bacteria) - Improved blood glucose (reduce cholesterol, blood sugar and uric acid)
| Packaging |
|---|
| - |
Related Ingredients
Need specialist support? Let's talk
Speak to one of our specialist team and get the expert support you need.
Get in Touch:quality(80))
:quality(80))
:quality(80))
:quality(80))
:quality(80))